We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
51
Amgen
AMGN
$201B
$27.4M 0.62%
123,423
+3,911
+3% +$908K
TYL icon
52
Tyler Technologies
TYL
$11.9B
$27.4M 0.61%
65,711
-1,693
-3% -$652K
PEP icon
53
PepsiCo
PEP
$184B
$24.4M 0.55%
131,485
-5,197
-4% -$970K
NVDA icon
54
NVIDIA
NVDA
$5.06T
$19.7M 0.44%
464,930
-188,560
-29% -$6.26M
NSC icon
55
Norfolk Southern
NSC
$78.3B
$18.5M 0.41%
81,436
+65,140
+400% +$13.8M
BRK.A icon
56
Berkshire Hathaway Class A
BRK.A
$1.06T
$17.6M 0.4%
34
CMI icon
57
Cummins
CMI
$91.8B
$16.7M 0.37%
67,970
-1,450
-2% -$328K
CSCO icon
58
Cisco
CSCO
$444B
$16.7M 0.37%
322,048
-13,647
-4% -$671K
AXP icon
59
American Express
AXP
$233B
$16M 0.36%
92,100
-31,514
-25% -$5.08M
META icon
60
Meta Platforms (Facebook)
META
$1.54T
$15.8M 0.35%
54,919
+42,971
+360% +$10.6M
WMT icon
61
Walmart Inc
WMT
$863B
$15.7M 0.35%
299,841
-4,380
-1% -$221K
BDX icon
62
Becton Dickinson
BDX
$42.1B
$15.3M 0.34%
57,902
-1,114
-2% -$283K
BSCQ icon
63
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.66B
$14.5M 0.32%
763,827
-26,299
-3% -$502K
IDXX icon
64
Idexx Laboratories
IDXX
$42.5B
$13M 0.29%
25,849
-131
-0.5% -$62.8K
CSX icon
65
CSX Corp
CSX
$98.1B
$13M 0.29%
379,960
-14,190
-4% -$449K
PH icon
66
Parker-Hannifin
PH
$124B
$12.4M 0.28%
31,818
-898
-3% -$304K
AFL icon
67
Aflac
AFL
$63.3B
$11.9M 0.27%
171,011
-1,302
-0.8% -$87.1K
DEO icon
68
Diageo
DEO
$45.7B
$11.5M 0.26%
66,484
-5,112
-7% -$913K
LLY icon
69
Eli Lilly
LLY
$1.06T
$11.5M 0.26%
24,457
+3,146
+15% +$1.32M
IBM icon
70
IBM
IBM
$194B
$10.9M 0.25%
81,627
-2,569
-3% -$332K
NKE icon
71
Nike
NKE
$60.8B
$9.57M 0.21%
86,705
-8,832
-9% -$1.03M
ADP icon
72
Automatic Data Processing
ADP
$97.1B
$9.19M 0.21%
41,811
-2,334
-5% -$503K
INTC icon
73
Intel
INTC
$504B
$8.27M 0.19%
247,299
-56,324
-19% -$1.77M
MDLZ icon
74
Mondelez International
MDLZ
$77.1B
$8.04M 0.18%
110,161
+757
+0.7% +$55.9K
PXD
75
DELISTED
Pioneer Natural Resource Co.
PXD
$7.98M 0.18%
38,499
-8,597
-18% -$1.81M

Similar funds

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.